Alzchem Group - Public Comps and Valuation Multiples

Alzchem Group Overview

About Alzchem Group

Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

Founded

1908

HQ

Employees

1.7K+

Website

alzchem.com

Sectors

Chemicals

Financials

LTM Revenue $662M

LTM EBITDA $130M

EV

$1.8B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Alzchem Group Financials

As of September 2025, Alzchem Group reported last 12-month revenue of $662M and EBITDA of $130M.

In the same period, Alzchem Group generated $426M in LTM gross profit and $68.1M in net income.

See Alzchem Group valuation multiples based on analyst estimates

Alzchem Group P&L

In the most recent fiscal year, Alzchem Group reported revenue of $641M and EBITDA of $124M.

Alzchem Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Alzchem Group valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$662M	XXX	$641M	XXX	XXX	XXX
Gross Profit	$426M	XXX	$417M	XXX	XXX	XXX
Gross Margin	64%	XXX	65%	XXX	XXX	XXX
EBITDA	$130M	XXX	$124M	XXX	XXX	XXX
EBITDA Margin	20%	XXX	19%	XXX	XXX	XXX
EBIT	$98.5M	XXX	$90.4M	XXX	XXX	XXX
EBIT Margin	15%	XXX	14%	XXX	XXX	XXX
Net Profit	$68.1M	XXX	$62.5M	XXX	XXX	XXX
Net Margin	10%	XXX	10%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Alzchem Group including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $662M. EBITDA for the last twelve months was $130M. In the most recent fiscal year, Alzchem Group achieved $641M in revenue and $124M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$662M	Analyst estimates available to subscribers	$641M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$426M	Analyst estimates available to subscribers	$417M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	64.3% gross margin	Analyst estimates available to subscribers	65.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$130M	Analyst estimates available to subscribers	$124M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	19.7% EBITDA margin	Analyst estimates available to subscribers	19.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$98.5M	Analyst estimates available to subscribers	$90.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	14.9% EBIT margin	Analyst estimates available to subscribers	14.1% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$68.1M	Analyst estimates available to subscribers	$62.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.3% net profit margin	Analyst estimates available to subscribers	9.8% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Alzchem Group

This financial data table provides comprehensive performance metrics for Alzchem Group, a company based in Germany. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Alzchem Group generated $662M in revenue over the last twelve months.
The company achieved $130M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $426M.
Net income over the last twelve months reached $68.1M.

Fiscal Year Performance

In the most recent fiscal year, Alzchem Group reported $641M in total revenue.
Fiscal year EBITDA was $124M.
The company maintained a gross profit margin of 65.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 19.4%.
Net profit margin reached 9.8% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Alzchem Group. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Alzchem Group Stock Performance

Alzchem Group has current market cap of EUR 1.5B (or $1.8B), and EV of EUR 1.5B (or $1.8B).

Market Cap Evolution

Alzchem Group Stock Data

As of October 17, 2025, Alzchem Group's stock price is EUR 153 (or $177).

See Alzchem Group trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.8B	$1.8B	XXX	XXX	XXX	XXX	$6.71

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Alzchem Group Valuation Multiples

Alzchem Group's trades at 2.8x EV/Revenue multiple, and 14.2x EV/EBITDA.

See valuation multiples for Alzchem Group and 15K+ public comps

Alzchem Group Financial Valuation Multiples

As of October 17, 2025, Alzchem Group has market cap of $1.8B and EV of $1.8B.

Equity research analysts estimate Alzchem Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Alzchem Group has a P/E ratio of 26.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.8B	XXX	$1.8B	XXX	XXX	XXX
EV (current)	$1.8B	XXX	$1.8B	XXX	XXX	XXX
EV/Revenue	2.7x	XXX	2.8x	XXX	XXX	XXX
EV/EBITDA	13.6x	XXX	14.2x	XXX	XXX	XXX
EV/EBIT	18.0x	XXX	19.6x	XXX	XXX	XXX
EV/Gross Profit	4.2x	XXX	n/a	XXX	XXX	XXX
P/E	26.3x	XXX	28.6x	XXX	XXX	XXX
EV/FCF	32.8x	XXX	14.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Alzchem Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Alzchem Group Margins & Growth Rates

Alzchem Group's last 12 month revenue growth is 8%

Alzchem Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Alzchem Group's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alzchem Group's rule of X is 40% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Alzchem Group and other 15K+ public comps

Alzchem Group Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	8%	XXX	7%	XXX	XXX	XXX
EBITDA Margin	20%	XXX	19%	XXX	XXX	XXX
EBITDA Growth	14%	XXX	18%	XXX	XXX	XXX
Rule of 40	23%	XXX	28%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	40%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	4%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	51%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial